Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies

Conventional oral dosage forms may not always be optimal especially for those patients suffering from dysphasia or difficulty swallowing. Development of suitable oral thin films (OTFs), therefore, can be an excellent alternative to conventional dosage forms for these patient groups. Hence, the main...

Full description

Bibliographic Details
Main Authors: Jiaxiang Zhang, Anqi Lu, Rishi Thakkar, Yu Zhang, Mohammed Maniruzzaman
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/10/1613
_version_ 1797513394364874752
author Jiaxiang Zhang
Anqi Lu
Rishi Thakkar
Yu Zhang
Mohammed Maniruzzaman
author_facet Jiaxiang Zhang
Anqi Lu
Rishi Thakkar
Yu Zhang
Mohammed Maniruzzaman
author_sort Jiaxiang Zhang
collection DOAJ
description Conventional oral dosage forms may not always be optimal especially for those patients suffering from dysphasia or difficulty swallowing. Development of suitable oral thin films (OTFs), therefore, can be an excellent alternative to conventional dosage forms for these patient groups. Hence, the main objective of the current investigation is to develop oral thin film (OTF) formulations using novel solvent-free approaches, including additive manufacturing (AM), hot-melt extrusion, and melt casting. AM, popularly recognized as 3D printing, has been widely utilized for on-demand and personalized formulation development in the pharmaceutical industry. Additionally, in general active pharmaceutical ingredients (APIs) are dissolved or dispersed in polymeric matrices to form amorphous solid dispersions (ASDs). In this study, acetaminophen (APAP) was selected as the model drug, and Klucel™ hydroxypropyl cellulose (HPC) E5 and Soluplus<sup>®</sup> were used as carrier matrices to form the OTFs. Amorphous OTFs were successfully manufactured by hot-melt extrusion and 3D printing technologies followed by comprehensive studies on the physico-chemical properties of the drug and developed OTFs. Advanced physico-chemical characterizations revealed the presence of amorphous drug in both HME and 3D printed films whereas some crystalline traces were visible in solvent and melt cast films. Moreover, advanced surface analysis conducted by Raman mapping confirmed a more homogenous distribution of amorphous drugs in 3D printed films compared to those prepared by other methods. A series of mathematical models were also used to describe drug release mechanisms from the developed OTFs. Moreover, the in vitro dissolution studies of the 3D printed films demonstrated an improved drug release performance compared to the melt cast or extruded films. This study suggested that HME combined with 3D printing can potentially improve the physical properties of formulations and produce OTFs with preferred qualities such as faster dissolution rate of drugs.
first_indexed 2024-03-10T06:15:58Z
format Article
id doaj.art-1b78c12d35034531a6dbf644e1a5a760
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T06:15:58Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-1b78c12d35034531a6dbf644e1a5a7602023-11-22T19:38:31ZengMDPI AGPharmaceutics1999-49232021-10-011310161310.3390/pharmaceutics13101613Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion TechnologiesJiaxiang Zhang0Anqi Lu1Rishi Thakkar2Yu Zhang3Mohammed Maniruzzaman4Pharmaceutical Engineering and 3D Printing (PharmE3D) Laboratory, Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USAPharmaceutical Engineering and 3D Printing (PharmE3D) Laboratory, Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USAPharmaceutical Engineering and 3D Printing (PharmE3D) Laboratory, Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USAPharmaceutical Engineering and 3D Printing (PharmE3D) Laboratory, Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USAPharmaceutical Engineering and 3D Printing (PharmE3D) Laboratory, Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USAConventional oral dosage forms may not always be optimal especially for those patients suffering from dysphasia or difficulty swallowing. Development of suitable oral thin films (OTFs), therefore, can be an excellent alternative to conventional dosage forms for these patient groups. Hence, the main objective of the current investigation is to develop oral thin film (OTF) formulations using novel solvent-free approaches, including additive manufacturing (AM), hot-melt extrusion, and melt casting. AM, popularly recognized as 3D printing, has been widely utilized for on-demand and personalized formulation development in the pharmaceutical industry. Additionally, in general active pharmaceutical ingredients (APIs) are dissolved or dispersed in polymeric matrices to form amorphous solid dispersions (ASDs). In this study, acetaminophen (APAP) was selected as the model drug, and Klucel™ hydroxypropyl cellulose (HPC) E5 and Soluplus<sup>®</sup> were used as carrier matrices to form the OTFs. Amorphous OTFs were successfully manufactured by hot-melt extrusion and 3D printing technologies followed by comprehensive studies on the physico-chemical properties of the drug and developed OTFs. Advanced physico-chemical characterizations revealed the presence of amorphous drug in both HME and 3D printed films whereas some crystalline traces were visible in solvent and melt cast films. Moreover, advanced surface analysis conducted by Raman mapping confirmed a more homogenous distribution of amorphous drugs in 3D printed films compared to those prepared by other methods. A series of mathematical models were also used to describe drug release mechanisms from the developed OTFs. Moreover, the in vitro dissolution studies of the 3D printed films demonstrated an improved drug release performance compared to the melt cast or extruded films. This study suggested that HME combined with 3D printing can potentially improve the physical properties of formulations and produce OTFs with preferred qualities such as faster dissolution rate of drugs.https://www.mdpi.com/1999-4923/13/10/1613additive manufacturingamorphous solid dispersionoral thin filmhot-melt extrusiondissolution kinetics
spellingShingle Jiaxiang Zhang
Anqi Lu
Rishi Thakkar
Yu Zhang
Mohammed Maniruzzaman
Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies
Pharmaceutics
additive manufacturing
amorphous solid dispersion
oral thin film
hot-melt extrusion
dissolution kinetics
title Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies
title_full Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies
title_fullStr Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies
title_full_unstemmed Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies
title_short Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies
title_sort development and evaluation of amorphous oral thin films using solvent free processes comparison between 3d printing and hot melt extrusion technologies
topic additive manufacturing
amorphous solid dispersion
oral thin film
hot-melt extrusion
dissolution kinetics
url https://www.mdpi.com/1999-4923/13/10/1613
work_keys_str_mv AT jiaxiangzhang developmentandevaluationofamorphousoralthinfilmsusingsolventfreeprocessescomparisonbetween3dprintingandhotmeltextrusiontechnologies
AT anqilu developmentandevaluationofamorphousoralthinfilmsusingsolventfreeprocessescomparisonbetween3dprintingandhotmeltextrusiontechnologies
AT rishithakkar developmentandevaluationofamorphousoralthinfilmsusingsolventfreeprocessescomparisonbetween3dprintingandhotmeltextrusiontechnologies
AT yuzhang developmentandevaluationofamorphousoralthinfilmsusingsolventfreeprocessescomparisonbetween3dprintingandhotmeltextrusiontechnologies
AT mohammedmaniruzzaman developmentandevaluationofamorphousoralthinfilmsusingsolventfreeprocessescomparisonbetween3dprintingandhotmeltextrusiontechnologies